This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Nanophagix LLC. Active years: 2021-2025.
Company Filing History:
Years Active: 2021-2025
Title: H Donlon Skerrett: Innovator in Drug Delivery and Imaging
Introduction
H Donlon Skerrett is a notable inventor based in Wayne, PA (US), recognized for his contributions to the field of drug delivery and imaging. With a total of two patents to his name, Skerrett has made significant advancements in the development of compounds that target macrophages and modulate the activity of the mammalian target of rapamycin (mTor).
Latest Patents
Skerrett's latest patents focus on drug delivery and imaging chemical conjugates. These inventions relate to compounds capable of entering macrophages and modulating mTor activity, which is crucial for treating mTor-associated diseases. The patents also encompass methods for imaging mTor in subjects, particularly within macrophages, showcasing the innovative applications of his research.
Career Highlights
Skerrett is affiliated with Nanophagix LLC, where he continues to explore the potential of his inventions in the pharmaceutical and medical fields. His work emphasizes the importance of targeted drug delivery systems and the role of imaging in understanding disease mechanisms.
Collaborations
Some of Skerrett's notable coworkers include Steven Jay Adelman and William Alvin Kinney, who have contributed to the collaborative efforts in advancing the research and development of innovative solutions in drug delivery.
Conclusion
H Donlon Skerrett's work exemplifies the intersection of innovation and practical application in the medical field. His patents reflect a commitment to improving treatment options for diseases associated with mTor, highlighting the importance of targeted therapies in modern medicine.